Purchase Order 75N90025P00706
Award Date
9/12/25
Potential Completion Date
9/11/26
Potential Value
$47K
Federal Agency
NIH Clinical Center
Awardee
Therakos LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hazelwood, MO 63042, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) Clinical Center awarded a $44,385 firm fixed-price purchase order to Therakos, Inc. to provide Therakos CELLEX Photopheresis System procedural kits. This award supports the NIH Clinical Center's medical research and patient care activities. Therakos, Inc. is a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The company has held multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans...
This federal contract award to Therakos, Inc., a foreign-owned for-profit organization, is for the delivery of CELLEX USA KITS to the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) Clinical Center. The $44,385.00 firm fixed price purchase order has an April 16, 2024 award date and an April 15, 2025 completion date. The contract does not have a set-aside designation. Therakos, as the prime contractor, provides photopheresis products and services to U.S. federal...
The National Institutes of Health (NIH) Clinical Center awarded a $44,385.00 firm-fixed price purchase order to Therakos, Inc., a foreign-owned, for-profit corporation, for the procurement of 5 cases of Therakos Cellex Photopheresis System Procedural Kits. These kits are required for emergent Extracorporeal Photopheresis (ECP) procedures for Clinical Center patients. The acquisition was conducted using Simplified Acquisition Procedures under Federal Acquisition Regulation (FAR) Part 13, as...
This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Therakos, Inc., a foreign-owned for-profit company, for the delivery of THERAKOS CELLEX Kits. The contract has a potential value of $44,385.00 and a completion date of July 3, 2024. The contract is not associated with any socioeconomic set-aside program. Therakos, Inc. manufactures and distributes photopheresis products and...
The National Institutes of Health (NIH) Clinical Center has awarded a firm-fixed price purchase order contract to Therakos, Inc., a foreign-owned, for-profit corporation, for the delivery of five cases of Cellex USA Photopheresis System Procedural Kits. These specialized medical kits are essential for Extracorporeal Photopheresis (ECP) procedures performed at the NIH Clinical Center to treat various conditions, including cutaneous T-cell lymphoma and graft-versus-host disease. The contract,...
This contract award to Therakos, Inc., a foreign-owned, for-profit corporation, provides $46,545.00 for the purchase of Cellex Photopheresis System Procedural Kits for the National Institutes of Health (NIH) Clinical Center. The contract is a Firm Fixed Price Purchase Order with an ultimate completion date of April 6, 2025. Therakos is a specialized medical device and pharmaceutical company that produces equipment and supplies used in extracorporeal photopheresis (ECP) treatments, which are...
This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis medical technology and pharmaceutical products. The $382,096 firm fixed-price purchase order is for medical and surgical instruments, equipment, and supplies. The contract has no set-aside designation. Therakos, Inc. provides critical medical equipment, procedural kits, and specialized medications, primarily...
The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH) Clinical Center awarded a $10,901.52 firm fixed-price purchase order to Therakos, Inc., a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The contract, awarded on July 31, 2024, runs through January 30, 2025 and is for the supply of the UVADEX medication used in the CELLEX Photopheresis System. Therakos, Inc. is the prime contractor and no set-aside...
The Department of Health and Human Services' National Institutes of Health Clinical Center has awarded a firm fixed price purchase order contract to Therakos, Inc., a foreign-owned for-profit organization, to provide Therakos reagents. The contract has a potential value of $145,020.00 and a completion date of October 31, 2020. This contract is not set aside. Therakos, Inc. is the prime contractor and there are no major subcontractors identified. The National Institutes of Health Clinical Center,...
This contract award to Therakos, Inc. is for the delivery of THERAKOS CELLEX KITS, a specialized medical product used in extracorporeal photopheresis procedures. The $44,385.00 fixed-price purchase order was issued by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. Therakos, Inc. is the prime contractor for this award and provides photopheresis products and services to various government healthcare agencies. The contract is not designated as a set-aside....